Image: David Fleg [CC BY 2.0], via Flickr
Paris-Saclay University heads winning bid centred on site in Villejuif
A group of universities, research institutions, pharmaceutical companies and hospitals in the southern Paris suburb of Villejuif will receive between €80 million and €100m over the next decade to create an interlinked cancer research and care biocluster.
The French government announced the Paris-Saclay Cancer Cluster (PSCC) as the winner of its first funding competition for such a partnership on 5 December. Villejuif is already the home of the Gustave-Roussy Hospital (pictured), Europe’s largest specialist cancer hospital, which has several research units attached, and will combine medical research with therapeutic facilities.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.